Work Files Saved Searches
   My Account                                                  Search:   Quick/Number   Boolean   Advanced   Derwent    Help   


 The Delphion Integrated View

  Buy Now:   Buy PDF- 14pp  PDF  |   File History  |   Other choices   
  Tools:  Citation Link  |  Add to Work File:    
  View:  Expand Details   |  INPADOC   |  Jump to: 
  Go to:  Derwent  
 Email this to a friend  Email this to a friend 
       
Title: US6022697: Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus
[ Derwent Title ]


Country: US United States of America

View Images High
Resolution

 Low
 Resolution

 
14 pages

 
Inventor: Kaufman, Daniel L.; Santa Monica, CA
Tian, Jide; Los Angeles, CA

Assignee: The Regents of the University of California, Oakland, CA
other patents from UNIVERSITY OF CALIFORNIA, THE REGENTS OF (599425) (approx. 4,840)
 News, Profiles, Stocks and More about this company

Published / Filed: 2000-02-08 / 1997-07-09

Application Number: US1997000890152

IPC Code: Advanced: A61K 39/00; G01N 33/564; G01N 33/68;
Core: more...
IPC-7: C07K 1/00; G01N 33/53; G01N 33/564;

ECLA Code: A61K39/00D4; G01N33/564; G01N33/68B; S01N333/47A5; S01N800/04A; S01N800/52;

U.S. Class: Current: 435/007.24; 435/007.92; 436/501; 436/506; 530/350; 530/351;
Original: 435/007.24; 435/007.92; 436/501; 436/506; 530/351; 530/350;

Field of Search: 435/7.24,7.92 436/506,501 530/351,350

Government Interest:

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
    This invention was made with Government support under GRANT NO. BK48455-01, awarded by NIH. The Government has certain rights in this invention.

Priority Number:
1997-07-09  US1997000890152
1996-11-29  US1996000758414

Abstract:     Methods for detecting the status of an insulin-dependent diabetes mellitus (IDDM)-associated autoimmune response in a mammal are provided. Specifically, the ratio of the frequency of T helper 1 cells to T helper 2 cells specific for a pancreatic beta -cell associated antigen is indicative of the status of the autoimmune response. The methods may be employed prior to the onset of the clinical symptoms of the disease, thereby allowing identification of those at risk for developing clinical symptoms of IDDM, or subsequent to pancreatic tissue transplantation, for example, to measure the efficacy of treatment directed to enhancing the lifetime of the tissue transplant. Methods for prolonging the survival of tissue transplants are also provided. Specifically, a tissue-associated antigen is administered to the mammal which serves to shift the pathogenic Th1 response associated with pathological immunity toward a protective Th2 response.

Attorney, Agent or Firm: Flehr Hohbach Test Albritton & Herbert LLP ; Lorenz, Todd A. ;

Primary / Asst. Examiners: Saunders, David; VanderVegt, F. Pierre

INPADOC Legal Status: Show legal status actions          Buy Now: Family Legal Status Report

       
Related Applications: Go to Result Set: 2 patent(s) that list this one as related
Application Number Filed Patent Pub. Date  Title
US1996000758414 1996-11-29       


       
Parent Case:     This application is a continuation-in-part of application Ser. No. 08/758,414, filed Nov. 29, 1996, now abandoned.

Designated Country: AL AM AP AT AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE EP ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT 

Family: Show 7 known family members

First Claim:
Show all 9 claims
What is claimed is:     1. A method for detecting the status of an IDDM-associated autoimmune response in a mammal, said method comprising determining the ratio of T helper 1 to T helper 2 cells in said mammal each of which are specific for the same pancreatic β-cell-associated antigen, wherein said ratio is indicative of the status of said autoimmune response in said mammal.

Background / Summary: Show background / summary

Drawing Descriptions: Show drawing descriptions

Description: Show description

Forward References: Show 1 U.S. patent(s) that reference this one

       
U.S. References: Go to Result Set: All U.S. references   |  Forward references (1)   |   Backward references (0)   |   Citation Link

       
Foreign References:
Buy
PDF
Publication Date IPC Code Assignee   Title
Buy PDF- 49pp WO9527500 1995-10  A61K 38/00 BRIGHAM AND WOMEN'S HOSPITAL TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES 
Buy PDF- 69pp WO9606630 1996-03  A61K 38/08 KUMAR, Vipin METHODS AND COMPOSITIONS FOR MODULATING A T CELL RESPONSE 
Buy PDF- 68pp WO9639176 1996-12  A61K 39/00 BRIGHAM & WOMEN'S HOSPITAL USE OF ORAL TOLERANCE TO SUPPRESS BOTH Th1 AND Th2 IMMUNE RESPONSES AND TO SUPPRESS ANTIBODY PRODUCTION 
Buy PDF- 39pp WO9702016 1997-01  A61K 9/127 COHEN IRUN R PREPARATIONS AND METHODS FOR THE TREATMENT OF T CELL MEDIATED DISEASES 
Buy PDF- 34pp WO9702052 1997-01  A61K 49/00 COHEN IRUN R METHOD FOR DETECTING OR MONITORING THE EFFECTIVENESS OF TREATMENT OF T CELL MEDIATED DISEASES 


Other Abstract Info: CHEMABS 129(03)026988K CHEMABS 132(11)136404M CHEMABS 132(11)136404M DERABS C1998-322870

Other References:
  • Liblau, RS et al. Immunology Today. 16:34-38, 1995. (5 pages) Cited by 13 patents [ISI abstract]
  • Tian, J et al. J. Exp. Med. 183:1561-1567, Apr. 1996. (7 pages) [ISI abstract]
  • Rocken et al., Immunology Today 17(5):225-231 (1996). (7 pages) [ISI abstract]
  • Mosmann et al., Immunology Today 17(30:138-146 (1996). (9 pages) Cited by 8 patents [ISI abstract]
  • Tisch, Roland et al., "Immune Response to Glutamic Acid Decarboxylase Correlates with Insulitis in non-obese diabetic mice", Nature, vol. 366, pp. 72-75 (Nov. 4, 1993). (4 pages) Cited by 20 patents [ISI abstract]
  • Kaufman, Daniel L. et al., "Spontaneous Loss of T-cell Tolerance to Glutamic Acid Decarboxylase in Murine Insulin-Dependent Diabetes", Nature, vol. 366, pp. 69-72 (Nov. 4, 1993). (4 pages) Cited by 24 patents [ISI abstract]


  • Continuity Data:
    Application Number Filed Notes

    US2000000735422 2000-12-12  is a continuation of
    US1998000119922  1998-07-21   (granted)
         US6207159 issued 2001-03-27   Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus

    US1998000119922 1998-07-21  is a division of
    >US1997000890152<  1997-07-09   (granted)
         US6022697 issued 2000-02-08   Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus

    >US1997000890152< 1997-07-09  is a continuation in part of
    US1996000758414  1996-11-29   (abandoned)


    Inquire Regarding Licensing

    Powered by Verity


    Plaques from Patent Awards      Gallery of Obscure PatentsNominate this for the Gallery...

    Thomson Reuters Copyright © 1997-2010 Thomson Reuters 
    Subscriptions  |  Web Seminars  |  Privacy  |  Terms & Conditions  |  Site Map  |  Contact Us  |  Help